Publikationen, an denen er mitarbeitet Ignacio Martín-Loeches (25)

2024

  1. Profiling the dysregulated immune response in sepsis: overcoming challenges to achieve the goal of precision medicine

    The Lancet Respiratory Medicine, Vol. 12, Núm. 4, pp. 305-322

2023

  1. Model-interpreted outcomes of artificial neural networks classifying immune biomarkers associated with severe infections in ICU

    Frontiers in Immunology, Vol. 14

  2. Transcriptomics reveals shared immunosuppressive landscapes in ventilator-associated lower respiratory tract infections (VA-LRTI) patients

    Expert Review of Anti-Infective Therapy, Vol. 21, Núm. 10, pp. 1135-1141

2022

  1. Evaluation of Respiratory Sequelae in Patients With COVID-19, Where we are and Where we are Going. CIBERESUCICOVID and RECOVID Studies to Compare Patients Admitted to ICU vs Conventional Ward

    Archivos de Bronconeumologia

  2. ICU-Acquired Pneumonia Is Associated with Poor Health Post-COVID-19 Syndrome

    Journal of Clinical Medicine, Vol. 11, Núm. 1

2021

  1. Evaluation of Respiratory Sequelae in Patients With COVID-19, Where we are and Where we are Going. CIBERESUCICOVID and RECOVID Studies to Compare Patients Admitted to ICU vs Conventional Ward

    Archivos de Bronconeumologia

  2. The COVID-19 puzzle: deciphering pathophysiology and phenotypes of a new disease entity

    The Lancet Respiratory Medicine, Vol. 9, Núm. 6, pp. 622-642

2019

  1. Current gaps in sepsis immunology: new opportunities for translational research

    The Lancet Infectious Diseases, Vol. 19, Núm. 12, pp. e422-e436

2017

  1. The protective association of endogenous immunoglobulins against sepsis mortality is restricted to patients with moderate organ failure

    Annals of Intensive Care, Vol. 7, Núm. 1

2014

  1. IgA level in plasma as a differential factor for influenza infection in severe viral pneumonia

    Journal of Clinical Virology

  2. Inflammation and infection in critical care medicine

    Mediators of Inflammation

2013

  1. IgM levels in plasma predict outcome in severe pandemic influenza

    Journal of Clinical Virology, Vol. 58, Núm. 3, pp. 564-567

  2. Macrolide-based regimens in absence of bacterial co-infection in critically ill H1N1 patients with primary viral pneumonia

    Intensive Care Medicine, Vol. 39, Núm. 4, pp. 693-702

  3. Managing data and knowledge for the InmunoFlu research project

    HEALTHINF 2013 - Proceedings of the International Conference on Health Informatics

2012

  1. Critical COPD respiratory illness is linked to increased transcriptomic activity of neutrophil proteases genes

    BMC Research Notes, Vol. 5

  2. Immunological monitoring to prevent and treat sepsis

    Critical Care

  3. Interleukin-6 is a potential biomarker for severe pandemic H1N1 influenza a infection

    PLoS ONE, Vol. 7, Núm. 6

  4. Intubated patients developing tracheobronchitis or pneumonia have distinctive complement system gene expression signatures in the pre-infection period: A pilot study

    Medicina Intensiva, Vol. 36, Núm. 4, pp. 257-263

  5. Viral infection is associated with an increased proinflammatory response in chronic obstructive pulmonary disease

    Viral Immunology, Vol. 25, Núm. 4, pp. 249-253

2011

  1. Direct association between pharyngeal viral secretion and host cytokine response in severe pandemic influenza

    BMC Infectious Diseases, Vol. 11